9 results
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... Action: Inhibits DPP ... Januvia) - Once/day tablet ... Onglyza) - Once/day tablet ... #Summary #DM2 #diabetes
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... This chart summarizes ... pharmacotherapy #table ... #medications #diabetes
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... events TZDs DPP ... EricsMedicalLectures/featured #diabetes ... #medications #table
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
kidney disease, DPP4i ... sulfonylurea; T2D. type 2 diabetes ... type 2 diabetes; ... KDIGO2020 #CKD #Diabetes ... management #treatment #CHART
Diagnostic criteria for diabetes flowchart. Visit gramproject.com for more medical diagrams, tables and flowcharts for use
Diagnostic criteria for diabetes ... medical diagrams, tables ... #diagnosis #algorithm ... #diabetes
Insulin Comparison Chart

Insulin Types - Onset (hours) - Peak Glycemic Effect (hours) - Duration (hours)
 •
Insulin Comparison Chart ... Insulin #Comparison #Table ... #pharmacology #diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP ... insulin in Type 1 Diabetes ... monitors in Type 1 Diabetes ... pharmacology #comparison #table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
drug to remain stable ... empagliflozin and DPP4 ... #semaglutide #Diabetes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
functional status - Able ... metabolic equivalent able ... event, follow ACC algorithm ... Stable patients ... Diabetes regimen